Quick Takeaways
- Joseph E. Payne has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $5,143.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Joseph E. Payne
- Location
- San Diego, CA
- Summary
- The estimated net worth of Joseph E. Payne is at least $5,143 dollars as of 19 Dec 2025. Joseph E. Payne is the Director of Vallon Pharmaceuticals, Inc. and owns shares of GRI Bio, Inc. (GRI) stock worth about $5.1K.
- Signature
- /s/ Ilan Katz, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Joseph E. Payne and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Vallon Pharmaceuticals, Inc. ($5,143).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Joseph E. Payne
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GRI | Vallon Pharmaceuticals, Inc. | Director | $5,143 | 09 Jun 2022 | ||
| ARCT | Arcturus Therapeutics Holdings Inc. | President and CEO, Director | 17 Dec 2025 |
Insider Transactions Reported by Joseph E. Payne:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.